Overactive Bladder Telemedicine Non-inferiority Trial
NCT05117918 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 177
Last updated 2023-12-12
Summary
In this study, the investigators aim to validate the telemedicine paradigm as a feasible alternative to traditional in-person clinic visits for the management of overactive bladder (OAB).
Conditions
Interventions
- OTHER
-
SUFU Clinical Care Pathway for Overactive Bladder
Treatment of OAB via the SUFU clinical care pathway
- OTHER
-
Telemedicine
Delivery of care via telemedicine
Sponsors & Collaborators
-
University of California, Los Angeles
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-07-01
- Primary Completion
- 2023-08-31
- Completion
- 2023-08-31
Countries
- United States
Study Locations
More Related Trials
-
InSite for Over Active Bladder
NCT00547378 ·Status: COMPLETED ·Phase: PHASE4
-
OnabotulinumtoxinA Bladder Injection Study
NCT03523091 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
NCT00912964 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating a Digital Intervention for Overactive Bladder
NCT05170100 ·Status: COMPLETED ·Phase: NA
-
Study of V117957 in Overactive Bladder Syndrome
NCT06024642 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
NCT00662909 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
NCT01029015 ·Status: COMPLETED
-
A Placebo-Controlled Study of MK0634 in Patients With Overactive Bladder (0634-007)
NCT00231790 ·Status: COMPLETED ·Phase: PHASE2
-
Mirabegron Combined With Behavioral Intervention for Overactive Bladder:a Prospective Multicenter Randomized Controlled Clinical Study
NCT05452434 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
NCT00688688 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Transcutaneous Versus Percutaneous Posterior Tibial Nerve Stimulation in the Overactive Bladder.
NCT04483817 ·Status: UNKNOWN ·Phase: NA
-
A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo
NCT00350636 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions
NCT01598103 ·Status: TERMINATED ·Phase: PHASE2
-
To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder
NCT04917315 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)
NCT00410514 ·Status: COMPLETED ·Phase: PHASE2
-
Developing a Simple Test to Diagnose Overactive Bladder
NCT05572918 ·Status: UNKNOWN
-
A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008)
NCT01314872 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study Evaluating the Usability of the Oabi Mobile Application
NCT04534946 ·Status: COMPLETED
-
Role of Combination Therapy in Women With Refractory Overactive Bladder
NCT06438861 ·Status: WITHDRAWN ·Phase: NA
-
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
NCT05878951 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
NCT00689104 ·Status: COMPLETED ·Phase: PHASE3
-
Sequencing and Combination of Mirabegron and TTNS in Overactive Bladder Syndrome: a Multicenter, Randomized, Open-label, Crossover Trial
NCT05188742 ·Status: UNKNOWN ·Phase: PHASE4
-
Educating Patients on Management of Overactive Bladder: Written Versus Verbal Instructions
NCT02197533 ·Status: COMPLETED ·Phase: NA
-
A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)
NCT00454896 ·Status: COMPLETED ·Phase: PHASE3
-
Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).
NCT05211193 ·Status: COMPLETED